278 related articles for article (PubMed ID: 30024537)
1. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
[TBL] [Abstract][Full Text] [Related]
2. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis.
Zhang L; Jiang Y; Jiao P; Deng X; Xie Y
Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840
[TBL] [Abstract][Full Text] [Related]
3. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
4. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
[TBL] [Abstract][Full Text] [Related]
5. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
[TBL] [Abstract][Full Text] [Related]
6. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
8. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
[TBL] [Abstract][Full Text] [Related]
9. CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.
He WP; Zhou J; Cai MY; Xiao XS; Liao YJ; Kung HF; Guan XY; Xie D; Yang GF
BMC Cancer; 2012 Sep; 12():437. PubMed ID: 23020525
[TBL] [Abstract][Full Text] [Related]
10. CHD1L: a novel oncogene.
Cheng W; Su Y; Xu F
Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of LINC00460 overexpression in solid tumours: a meta-analysis.
Dai C; Zhang Y; Ni H; Kuang Y; Xu Z
Postgrad Med J; 2020 May; 96(1135):286-295. PubMed ID: 32054779
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of LOXL2 in cancers: A systematic review and meta-analysis.
Zhang X; Huang J; You F; Li W; Zou Z
J Cell Physiol; 2019 Nov; 234(11):21369-21379. PubMed ID: 31032923
[TBL] [Abstract][Full Text] [Related]
15. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of CapG in various cancers: Evidence from a meta-analysis.
Lang Z; Chen Y; Zhu H; Sun Y; Zhang H; Huang J; Zou Z
Pathol Res Pract; 2019 Dec; 215(12):152683. PubMed ID: 31685300
[TBL] [Abstract][Full Text] [Related]
17. CHD1L is a novel independent prognostic factor for gastric cancer.
Su Z; Zhao J; Xian G; Geng W; Rong Z; Wu Y; Qin C
Clin Transl Oncol; 2014 Aug; 16(8):702-7. PubMed ID: 24258459
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of Cks1 in cancer: Evidence from a meta-analysis.
Zhang Y; Chen Y; You F; Li W; Lang Z; Zou Z
J Cell Physiol; 2019 Aug; 234(8):13423-13430. PubMed ID: 30605238
[TBL] [Abstract][Full Text] [Related]
19. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis.
Zhang C; Zhou C; Xu J; Xue S
Dis Markers; 2022; 2022():8443932. PubMed ID: 35126792
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
Lin H; Zhao X; Xia L; Lian J; You J
Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
